Cassidy v. Boehringer Ingelheim Pharmaceuticals, Inc.
Mary Cassidy |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, GlaxoSmithKline LLC, Glaxosmithkline Holdings (Americas), Inc., Pfizer, Inc., Sanofi-Aventis U.S. LLC and Sanofi US Services Inc. |
23-880 |
June 13, 2023 |
U.S. Court of Appeals, Second Circuit |
Torts |
Docket Report
This docket was last retrieved on July 18, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 80 CURED DEFECTIVE JOINT APPENDIX, volumes 1-5, [ # 73 ], [ # 74 ], [ # 75 ], [ # 76 ], [ # 77 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3543230] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:46 PM] |
Filing 79 CURED DEFECTIVE BRIEF & SPECIAL APPENDIX, [ # 72 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3543227] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:44 PM] |
Filing 78 MOTION ORDER, granting motion to adjourn oral argument [ # 69 ] filed by Appellant Sanofi-Aventis U.S. LLC and Sanofi US Services Inc. in 23-877, FILED. [3543211][78] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:35 PM] |
Filing 77 JOINT APPENDIX, volume 5 of 5, (pp. 1036-1307), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543205] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:30 PM] |
Filing 76 JOINT APPENDIX, volume 4 of 5, (pp. 780-1035), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543199] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:28 PM] |
Filing 75 JOINT APPENDIX, volume 3 of 5, (pp. 530-779), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543196] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:24 PM] |
Filing 74 JOINT APPENDIX, volume 2 of 5, (pp. 261-529), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543192] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:21 PM] |
Filing 73 JOINT APPENDIX, volume 1 of 5, (pp. 1-260), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF.[3543189] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:19 PM] |
Filing 72 BRIEF & SPECIAL APPENDIX, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF. [3543185] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 02:15 PM] |
Filing 70 CURED DEFECTIVE MOTION, TO ADJOURN ORAL ARGUMENT, [ # 69 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3543083] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 12:56 PM] |
Filing 69 MOTION, to adjourn oral argument, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/18/2023 by CM/ECF. [3543073] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 12:52 PM] |
Filing 65 DEFECTIVE DOCUMENT, Joint Appendix, volumes 1-5, [56], [57], [58], [59], [60], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3542873] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 09:17 AM] |
Filing 64 DEFECTIVE DOCUMENT, Brief & Special Appendix, [55], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3542867] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 09:06 AM] |
Filing 63 DEFECTIVE DOCUMENT, MOTION, to adjourn oral argument, [61], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, FILED.[3542842] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/18/2023 08:43 AM] |
Filing 61 MOTION, to adjourn oral argument, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF. [3542754] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885]--[Edited 07/18/2023 by RW] [Entered: 07/17/2023 08:06 PM] |
Filing 60 JOINT APPENDIX, volume 5 of 5, (pp. 1036-1307), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542747] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:19 PM] |
Filing 59 JOINT APPENDIX, volume 4 of 5, (pp. 780-1035), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542746] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:15 PM] |
Filing 58 JOINT APPENDIX, volume 3 of 5, (pp. 530-779), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542745] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:13 PM] |
Filing 57 JOINT APPENDIX, volume 2 of 5, (pp. 261-529), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542744] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:10 PM] |
Filing 56 JOINT APPENDIX, volume 1 of 5, (pp. 1-260), on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF.[3542743] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:08 PM] |
Filing 55 BRIEF & SPECIAL APPENDIX, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC in 23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885, FILED. Service date 07/17/2023 by CM/ECF. [3542742] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/17/2023 07:05 PM] |
Filing 51 NEW CASE MANAGER, Ronald Willoughby, ASSIGNED.[3541402] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/14/2023 08:45 AM] |
Filing 43 ATTORNEY, Robert A. Izard Jr. for Mary Cassidy, in case 23-880 , [ # 40 ], ADDED.[3541215] [23-880] [Entered: 07/13/2023 04:49 PM] |
Filing 41 CURED DEFECTIVE Notice of Appearance as Additional Counsel, [ # 36 ], [ # 38 ], on behalf of Appellee Mary Cassidy, FILED.[3541206] [23-880] [Entered: 07/13/2023 04:46 PM] |
Filing 40 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Mary Cassidy, FILED. Service date 07/05/2023 by CM/ECF. [3537356] [23-880] [Entered: 07/05/2023 04:10 PM] |
Filing 38 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Mary Cassidy, FILED. Service date 07/05/2023 by CM/ECF. [3537255] [23-880] [Entered: 07/05/2023 02:55 PM] |
Filing 37 DEFECTIVE DOCUMENT, Notice of Appearance as Additional Counsel, [ # 33 ], on behalf of Appellee Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, Appellee Jerome Jay Berkowitz in 23-878, Appellee Armando Ramos in 23-879, Appellee Mary Cassidy in 23-880, Appellee John Corwin in 23-881, Appellee Thomas Vazzano in 23-882, Appellee Rafael Rolon in 23-883, Appellee Roderick Sullivan in 23-884, Appellee Anne Yost in 23-885, FILED.[3537032] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/05/2023 11:21 AM] |
Filing 36 DEFECTIVE DOCUMENT, Notice of Appearance as Additional Counsel, [ # 32 ], on behalf of Appellee Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, FILED.[3537005] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 07/05/2023 11:09 AM] |
Filing 35 ATTORNEY, Jaime Ashley Welsh for Boehringer Ingelheim Corporation Boehringer Ingelheim USA Corporation Boehringer Ingelheim Pharmaceuticals, Inc., in case 23-880, [ # 30 ], ADDED.[3536386] [23-880] [Entered: 06/30/2023 12:55 PM] |
Filing 34 CURED DEFECTIVE Form D, [ # 24 ], [ # 29 ], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED.[3536382] [23-880] [Entered: 06/30/2023 12:53 PM] |
Filing 33 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, Appellee Jerome Jay Berkowitz in 23-878, Appellee Armando Ramos in 23-879, Appellee Mary Cassidy in 23-880, Appellee John Corwin in 23-881, Appellee Thomas Vazzano in 23-882, Appellee Rafael Rolon in 23-883, Appellee Roderick Sullivan in 23-884, Appellee Anne Yost in 23-885, FILED. Service date 06/29/2023 by CM/ECF. [3535620] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/29/2023 12:04 PM] |
Filing 32 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellee Beth Bacher, Jerome Jay Berkowitz, Mary Cassidy, John Corwin, Armando Ramos, Rafael Rolon, Roderick Sullivan, Thomas Vazzano and Anne Yost in 23-877, Appellee Jerome Jay Berkowitz in 23-878, Appellee Armando Ramos in 23-879, Appellee Mary Cassidy in 23-880, Appellee John Corwin in 23-881, Appellee Thomas Vazzano in 23-882, Appellee Rafael Rolon in 23-883, Appellee Roderick Sullivan in 23-884, Appellee Anne Yost in 23-885, FILED. Service date 06/29/2023 by CM/ECF. [3535610] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/29/2023 11:49 AM] |
Filing 31 ELECTRONIC INDEX, in lieu of record, FILED.[3535207] [23-880] [Entered: 06/28/2023 04:17 PM] |
Filing 30 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/28/2023 by CM/ECF. [3535092] [23-880] [Entered: 06/28/2023 03:10 PM] |
Filing 29 FORM D, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/28/2023 by CM/ECF.[3535077] [23-880] [Entered: 06/28/2023 02:59 PM] |
Filing 28 ATTORNEY, James I. Glasser for Pfizer, Inc., in case 23-880, [ # 22 ], ADDED.[3534947] [23-880] [Entered: 06/28/2023 12:19 PM] |
Filing 27 ATTORNEY, Lauren R. Greenspoon for Glaxosmithkline Holdings (Americas), Inc. GlaxoSmithKline LLC, in case 23-880, [ # 17 ], ADDED.[3534942] [23-880] [Entered: 06/28/2023 12:17 PM] |
Filing 24 DEFECTIVE DOCUMENT, Form D, [11], on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED.[3534931] [23-880] [Entered: 06/28/2023 12:04 PM] |
Filing 22 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF. [3534560] [23-880] [Entered: 06/27/2023 05:18 PM] |
Filing 21 FORM D, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534559] [23-880] [Entered: 06/27/2023 05:15 PM] |
Filing 20 FORM C, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534556] [23-880] [Entered: 06/27/2023 05:14 PM] |
Filing 19 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Pfizer, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534554] [23-880] [Entered: 06/27/2023 05:13 PM] |
Filing 18 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellee Mary Cassidy, FILED. Service date 06/27/2023 by CM/ECF, email.[3534499] [23-880] [Entered: 06/27/2023 04:38 PM] |
Filing 17 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534440] [23-880] [Entered: 06/27/2023 04:04 PM] |
Filing 16 FORM D, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534414] [23-880] [Entered: 06/27/2023 03:45 PM] |
Filing 15 FORM C, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534412] [23-880] [Entered: 06/27/2023 03:44 PM] |
Filing 14 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534409] [23-880] [Entered: 06/27/2023 03:41 PM] |
Filing 13 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Glaxosmithkline Holdings (Americas), Inc. and GlaxoSmithKline LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534403] [23-880] [Entered: 06/27/2023 03:38 PM] |
Filing 12 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534361] [23-880] [Entered: 06/27/2023 02:38 PM] |
Filing 11 FORM D, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534353] [23-880] [Entered: 06/27/2023 02:35 PM] |
Filing 10 FORM C, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534350] [23-880] [Entered: 06/27/2023 02:34 PM] |
Filing 9 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF.[3534349] [23-880] [Entered: 06/27/2023 02:33 PM] |
Filing 8 FORM D, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/27/2023 by CM/ECF.[3534295] [23-880] [Entered: 06/27/2023 02:04 PM] |
Filing 7 FORM C, on behalf of Appellant Boehringer Ingelheim Corporation and Boehringer Ingelheim Pharmaceuticals, Inc., FILED. Service date 06/27/2023 by CM/ECF.[3534292] [23-880] [Entered: 06/27/2023 02:03 PM] |
Filing 6 ACKNOWLEDGMENT AND NOTICE OF APPEARANCE, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc. and Boehringer Ingelheim USA Corporation, FILED. Service date 06/27/2023 by CM/ECF.[3534290] [23-880] [Entered: 06/27/2023 02:02 PM] |
Filing 5 NOTICE OF APPEARANCE AS ADDITIONAL COUNSEL, on behalf of Appellant Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. Service date 06/27/2023 by CM/ECF. [3534241] [23-880] [Entered: 06/27/2023 01:32 PM] |
Filing 4 CASE CALENDARING, for the week of 09/18/2023, A, PROPOSED.[3531137] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/20/2023 01:10 PM] |
Filing 3 ORDER, dated 06/16/2023, setting Appellant's brief due date as July 17, 2023 and Appellees' brief due date as August 17, 2023. The reply brief is due by August 28, 2023. The Clerk is directed to set the appeal for argument as early as the week of September 18, 2023., FILED.[3530582] [23-877, 23-878, 23-879, 23-880, 23-881, 23-882, 23-883, 23-884, 23-885] [Entered: 06/16/2023 04:28 PM] |
Filing 2 DISTRICT COURT ORDER, entered in the district court as docket entry dated 01/17/2023, RECEIVED.[3528586] [23-880] [Entered: 06/13/2023 01:48 PM] |
Filing 1 NOTICE OF CIVIL APPEAL, with district court docket, on behalf of Appellant Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline LLC, Glaxosmithkline Holdings (Americas), Inc., Pfizer, Inc., Sanofi US Services Inc. and Sanofi-Aventis U.S. LLC, FILED. [3528549] [23-880] [Entered: 06/13/2023 01:21 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.